Project Details
Description
Study of FT538 in Combination with Daratumumab in Acute Myeloid Leukemia
| Status | Active |
|---|---|
| Effective start/end date | 1/1/21 → 12/31/26 |
Funding
- FATE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.